Delivery Order SPE2DX22D0010-SPE2D825FCN68

Award Date 1/9/25
Potential Completion Date 1/10/25
Potential Value $4.1K
Federal Agency
Medical Supply Chain
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major supplier of pharmaceutical products and medical supplies to the U.S. government. The award, valued at $1,868.64, is for the delivery of Focalin XR 30 mg capsules in quantities of 100s. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to $999,999,999.00 through December...
This federal contract award, valued at $4,509.34, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp. The contract is a Delivery Order for the supply of FOCALIN XR CAPS 10MG, a pharmaceutical product, with a period of performance ending on January 14, 2025. This award is associated with a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued at $999,999,999 and...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,376.18, is for the delivery of Focalin XR 40 mg capsules. The award is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical. This IDC, valued at up to $999,999,999.00, serves as the...
This federal contract award, valued at $2,161.06, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office division, a major supplier of pharmaceutical products and medical supplies to the U.S. government. The $12,509.69 firm-fixed-price delivery order is for the provision of Focalin XR 20 mg capsules. The award is part of Amerisourcebergen's Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which has a ceiling value of up to $999,999,999.00 through...
This federal contract award, valued at $8,457.40, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The delivery order is for the supply of Focalin XR Capsules, a prescription medication, and has a firm fixed price. This award is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. Under this single-award IDC,...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company. The contract, valued at $1,781.66, is for the delivery of Focalin XR 10 mg capsules in 100-count packages. The contract has a completion date of September 17, 2024 and is structured as a Firm Fixed Price Delivery Order. This award is not associated with any set-aside designation. As a significant supplier of...
This federal contract award, valued at $2,127.60, was issued by the Medical Supply Chain, a component of the Defense Logistics Agency (DLA) Troop Support. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Focalin XR capsules, a medication used to treat attention deficit hyperactivity disorder (ADHD). The contract has a completion date of September 24, 2024 and is structured as a firm-fixed price delivery order. This award is not...
This federal contract award, valued at $2,871.35, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Focalin XR capsules, a medication used to treat attention-deficit/hyperactivity disorder (ADHD). The contract is a Firm Fixed Price Delivery Order with a completion date of November 27, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,268.63 firm fixed-price delivery order is for the supply of Focalin XR 25 mg capsules. The award is part of a broader $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical products and medical supplies...
  • SPE2DX22D0010
    Indefinite Delivery Contract
  • SPE2DX22D0010-SPE2D825FCN68
    Delivery Order

This federal contract award, valued at $4,134.40, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp. The contract is for the delivery of Focalin XR capsules, a pharmaceutical product used in the treatment of medical conditions. This award is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, valued at $999,999,999 and running through November 2026. The IDC serves as a vehicle for the company to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. There was no set-aside designation for this specific award.

Generated 4/10/25, 11:49 AM